ibmk_a_920046_sm0001.pdf (189.14 kB)
Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review
journal contribution
posted on 2018-05-03, 13:54 authored by Paul Bălănescu, Anca Lădaru, Eugenia Bălănescu, Cristian Băicuş, Gheorghe Andrei DanContext: Systemic sclerosis (SSc) is an autoimmune disease with incompletely known physiopathology. There is a great challenge to predict its course and therapeutic response using biomarkers.
Objective: To critically review proteomic biomarkers discovered from biological specimens from systemic sclerosis patients using mass spectrometry technologies.
Methods: Medline and Embase databases were searched in February 2014.
Results: Out of the 199 records retrieved, a total of 20 records were included, identifying 116 candidate proteomic biomarkers.
Conclusion: Research in SSc proteomic biomarkers should focus on biomarker validation, as there are valuable mass-spectrometry proteomics studies in the literature.
History
Usage metrics
Categories
Keywords
Systemic sclerosis biomarkersreview proteomic biomarkers116 candidate proteomic biomarkersreview Contextmass-spectrometry-based proteomicsbiomarker validationmass-spectrometry proteomics studiesEmbase databasesFebruary 2014. Results199 recordsSSc proteomic biomarkersmass spectrometry technologiessclerosis patientsSystemic sclerosis20 records
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC